Medidata Solutions (NASDAQ:MDSO) will announce its earnings results before the market opens on Wednesday, February 7th. Analysts expect the company to announce earnings of $0.35 per share for the quarter.
Shares of Medidata Solutions (NASDAQ:MDSO) opened at $69.16 on Wednesday. Medidata Solutions has a one year low of $47.77 and a one year high of $85.92. The company has a current ratio of 1.29, a quick ratio of 3.37 and a debt-to-equity ratio of 0.61. The stock has a market cap of $4,120.00, a price-to-earnings ratio of 98.80, a price-to-earnings-growth ratio of 3.72 and a beta of 1.69.
In other news, EVP Michael I. Otner sold 10,000 shares of Medidata Solutions stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $70.88, for a total transaction of $708,800.00. Following the transaction, the executive vice president now owns 80,674 shares in the company, valued at approximately $5,718,173.12. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Rouven Bergmann sold 3,000 shares of Medidata Solutions stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $70.00, for a total value of $210,000.00. Following the transaction, the chief financial officer now owns 84,775 shares in the company, valued at approximately $5,934,250. The disclosure for this sale can be found here. In the last quarter, insiders have sold 244,010 shares of company stock worth $16,779,956. Insiders own 5.80% of the company’s stock.
Several equities research analysts have issued reports on MDSO shares. TheStreet cut shares of Medidata Solutions from a “b” rating to a “c+” rating in a research note on Thursday, December 14th. Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Wednesday, December 27th. Wells Fargo & Co lowered their target price on shares of Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating on the stock in a research note on Friday, October 27th. SunTrust Banks reaffirmed a “buy” rating and set a $92.00 target price on shares of Medidata Solutions in a research note on Friday, October 27th. Finally, Deutsche Bank began coverage on shares of Medidata Solutions in a research note on Friday, December 8th. They set a “buy” rating and a $78.00 target price on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $84.54.
TRADEMARK VIOLATION NOTICE: This story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/31/medidata-solutions-mdso-set-to-announce-quarterly-earnings-on-wednesday.html.
Medidata Solutions Company Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.